Seguir
Jorge Matias-Guiu
Jorge Matias-Guiu
Hospital Clinico San Carlos
Dirección de correo verificada de salud.madrid.org
Título
Citado por
Citado por
Año
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind …
RHJ Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M ...
The Lancet 364 (9431), 331-7, 2004
24392004
Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial
MT Matías-Guiu J, Ferro JM, Alvarez-Sabín J, Torres F, Jiménez MD, Lago A
Stroke. 2003 Apr;34(4):840-8. 34 (4), 840-8. doi: 10.1161/01.STR.0000063141.24, 2003
192*2003
Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
DBF Diener HC, Matias-Guiu J, Hartung E, Pfaffenrath V, Ludin HP, Nappi G
Cephalalgia 22 (3), 209-21, 2002
1432002
Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction
MLJM Martínez-Vila E, Guillén F, Villanueva JA, Matías-Guiu J, Bigorra J ...
Stroke. 21 (7), 1203-8, doi: 10.1161/01.str.21.7.1023., 1990
140*1990
Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
J Matías-Guiu, U Gomez-Pinedo, P Montero-Escribano, P Gomez-Iglesias, ...
Neurología (English Edition) 35 (3), 170-175, 2020
137*2020
Triflusal for preventing serious vascular events in people at high risk
TF Costa J, Ferro JM, Matias-Guiu J, Alvarez-Sabin J
Cochrane Database Syst Rev. 2005 (3), CD004296. doi: 10.1002/14651858.CD004296, 2005
122*2005
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: a case series of 60 patients from Madrid, Spain
P Montero-Escribano, J Matías-Guiu, P Gómez-Iglesias, J Porta-Etessam, ...
Multiple sclerosis and related disorders 42, 102185, 2020
1112020
One-year prevalence of migraine in Spain: a nationwide population-based survey
J Matías-Guiu, J Porta-Etessam, V Mateos, S Díaz-Insa, A Lopez-Gil, ...
Cephalalgia 31 (4), 463-470, 2011
1092011
Ischemic stroke in young adults I. Analysis of the etiological subgroups
J Alvarez, J Matias‐Guiu, J Sumalla, M Molins, R Insa, JM Molto, R Martin, ...
Acta neurologica scandinavica 80 (1), 28-34, 1989
941989
Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data
RHJ Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M ...
Cerebrovasc Dis. 253-61. doi: 10.1159/000076962. 17 (2-3), 253-61. doi: 10 …, 2004
92*2004
Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests
JA Matias-Guiu, A Cortés-Martínez, M Valles-Salgado, T Rognoni, ...
International psychogeriatrics 29 (1), 105-113, 2017
812017
Comparative diagnostic accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for screening of Alzheimer disease
JA Matias-Guiu, M Valles-Salgado, T Rognoni, F Hamre-Gil, ...
Dementia and geriatric cognitive disorders 43 (5-6), 237-246, 2017
762017
Astrocytes in neurodegenerative diseases (I): function and molecular description
MGJ Guillamón-Vivancos T, Gómez-Pinedo U
Neurologia 30 (3), 119-29. doi: 10.1016/j.nrl.2012.12.007, 2015
742015
Computed tomography in reversible ischaemic attacks: clinical and prognostic correlations in a prospective study
CA Dávalos A, Matías-Guiu J, Torrent O, Vilaseca J
J Neurol. 155-8. doi: 10.1007/BF00314306. 235 (3), 155-8. doi: 10.1007 …, 1988
71*1988
Management of neurological care during the COVID-19 pandemic
J Matías-Guiu, J Porta-Etessam, E Lopez-Valdes, I Garcia-Morales, ...
Neurología (English Edition) 35 (4), 233-237, 2020
64*2020
Amyloid PET imaging in multiple sclerosis: an 18F-florbetaben study
JA Matías-Guiu, MN Cabrera-Martín, J Matías-Guiu, C Oreja-Guevara, ...
BMC neurology 15 (1), 1-7, 2015
642015
Dementia, stroke and Parkinson's disease in Spanish populations: a review of door-to-door prevalence surveys
SP del Barrio JL, de Pedro-Cuesta J, Boix R, Acosta J, Bergareche A, Bermejo ...
Neuroepidemiology 24 (4), 179-88. doi: 10.1159/00008513, 2005
642005
CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole
M Yáñez, L Galán, J Matías-Guiu, A Vela, A Guerrero, AG García
Brain research 1423, 77-86, 2011
612011
Guía para el tratamiento preventivo de la isquemia cerebral
B Fuentes, E Díez-Tejedor, A Gil-Núñez, A Gil-Peralta, J Matías-Guiu
Guía para el diagnóstico y tratamiento del ictus. Barcelona: Prous Science …, 2006
60*2006
Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
M Timmers, JR Streffer, A Russu, Y Tominaga, H Shimizu, A Shiraishi, ...
Alzheimer's research & therapy 10 (1), 1-18, 2018
592018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20